CINOXACIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cinoxacin, and when can generic versions of Cinoxacin launch?
Cinoxacin is a drug marketed by Teva and is included in two NDAs.
The generic ingredient in CINOXACIN is cinoxacin. There are three drug master file entries for this compound. Additional details are available on the cinoxacin profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CINOXACIN?
- What are the global sales for CINOXACIN?
- What is Average Wholesale Price for CINOXACIN?
Summary for CINOXACIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,437 |
| DailyMed Link: | CINOXACIN at DailyMed |
Recent Clinical Trials for CINOXACIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Julio Ramirez | Early Phase 1 |
| University of Louisville | Early Phase 1 |
| James Graham Brown Cancer Center | Early Phase 1 |
Medical Subject Heading (MeSH) Categories for CINOXACIN
Anatomical Therapeutic Chemical (ATC) Classes for CINOXACIN
US Patents and Regulatory Information for CINOXACIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | CINOXACIN | cinoxacin | CAPSULE;ORAL | 073005-001 | Feb 28, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva | CINOXACIN | cinoxacin | CAPSULE;ORAL | 073006-001 | Feb 28, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
